Pacira BioSciences' Research & Development rose 3591.92% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 3404.33%. This contributed to the annual value of $81.6 million for FY2024, which is 697.64% up from last year.
Latest data reveals that Pacira BioSciences reported Research & Development of $26.0 million as of Q3 2025, which was up 3591.92% from $28.2 million recorded in Q2 2025.
Pacira BioSciences' Research & Development's 5-year high stood at $28.2 million during Q2 2025, with a 5-year trough of $11.6 million in Q3 2021.
Its 5-year average for Research & Development is $19.9 million, with a median of $19.4 million in 2022.
Per our database at Business Quant, Pacira BioSciences' Research & Development skyrocketed by 10903.52% in 2022 and then crashed by 2837.68% in 2023.
Over the past 5 years, Pacira BioSciences' Research & Development (Quarter) stood at $15.5 million in 2021, then grew by 12.83% to $17.5 million in 2022, then grew by 11.19% to $19.5 million in 2023, then rose by 22.78% to $23.9 million in 2024, then rose by 8.66% to $26.0 million in 2025.
Its Research & Development stands at $26.0 million for Q3 2025, versus $28.2 million for Q2 2025 and $25.3 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value